[Background] The unfolded protein response,autophagy and endoplasmic reticulum (ER) stress-induced apoptosis regulate tumor cell fate and have become novel signaling targets for the development of cancer therapeutic drugs.Curcumin has been used to treat several different cancers,including ovarian cancer,in clinical trials and research; however,the role of ER stress and autophagy in the therapeutic effects of curcumin and new curcumin analogues remains unclear.[Methods] Cell viability was determined using the MTT assay.Apoptosis was detected using flow cytometry with PI/Annexin VFITC staining.The expression levels of ER stress-and autophagy-related proteins were analyzed by western blotting.The activation of autophagy was detected using immunofluorescence staining.[Results] We demonstrated that B19 induced HO8910 cell apoptosis in a dose-responsive manner.We also determined and that this effect was associated with corresponding increases in a series of key components in the UPR and ER stress-mediated apoptosis pathways,followed by caspase 3 cleavage and activation.We also observed that B19 treatment induced autophagy in HO8910 cells.The inhibition of autophagy using 3-methyladenine (3-MA) increased levels of intracellular misfolded proteins,which enhanced ovarian cancer apoptosis.[Conclusions] Our data indicate that ER stress and autophagy play a role in the apoptosis that is induced by the curcumin analogue B19 in an epithelial ovarian cancer cell line and that autophagy inhibition can increase curcumin analogue-induced apoptosis by inducing severe ER stress.